Authors:
Violette, SM
Guan, W
Bartlett, C
Smith, JA
Bardelay, C
Antoine, E
Rickles, RJ
Mandine, E
Van Schravendijk, MR
Adams, SE
Lynch, BA
Shakespeare, WC
Yang, M
Jacobsen, VA
Takeuchi, CS
Macek, KJ
Bohacek, RS
Dalgarno, DC
Weigele, M
Lesuisse, D
Sawyer, TK
Baron, R
Citation: Sm. Violette et al., Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption, BONE, 28(1), 2001, pp. 54-64
Authors:
Kawahata, N
Yang, MG
Luke, GP
Shakespeare, WC
Sundaramoorthi, R
Wang, YH
Johnson, D
Merry, T
Violette, S
Guan, W
Bartlett, C
Smith, J
Hatada, M
Lu, XD
Dalgarno, DC
Eyermann, CJ
Bohacek, RS
Sawyer, TK
Citation: N. Kawahata et al., A novel phosphotyrosine mimetic 4 '-carboxymethyloxy-3 '-phosphonophenylalanine (Cpp): Exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain, BIOORG MED, 11(17), 2001, pp. 2319-2323
Authors:
Bohacek, RS
Dalgarno, DC
Hatada, M
Jacobsen, VA
Lynch, BA
Macek, KJ
Merry, T
Metcalf, CA
Narula, SS
Sawyer, TK
Shakespeare, WC
Violette, SM
Weigele, M
Citation: Rs. Bohacek et al., X-ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor, J MED CHEM, 44(5), 2001, pp. 660-663
Authors:
Shakespeare, WC
Bohacek, RS
Azimioara, MD
Macek, KJ
Luke, GP
Dalgarno, DC
Hatada, MH
Lu, XD
Violette, SM
Bartlett, C
Sawyer, TK
Citation: Wc. Shakespeare et al., Structure-based design of novel bicyclic nonpeptide inhibitors for the SrcSH2 domain, J MED CHEM, 43(21), 2000, pp. 3815-3819
Authors:
Shakespeare, WC
Bohacek, RS
Narula, SS
Azimioara, MD
Yuan, RW
Dalgarno, DC
Madden, L
Botfield, MC
Holt, DA
Citation: Wc. Shakespeare et al., An efficient synthesis of a 4 '-phosphonodifluoromethyl-3 '-formyl-phenylalanine containing Src SH2 ligand, BIOORG MED, 9(21), 1999, pp. 3109-3112